Related Articles
Are We Playing It Safe?
Tumor necrosis factor alpha inhibition and the risk of solid malignancies
New Guidance for Rheumatologists who Treat JIA
Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy
TNF Blockade for SLE
Reckless approach versus missed opportunity?
Cancer Risk for Patients with Juvenile Idiopathic Arthritis Taking TNF Inhibitors
WASHINGTON, D.C.—Juvenile idiopathic arthritis (JIA) patients taking TNF inhibitors don’t develop new cancers at a higher rate than JIA patients who don’t take TNF inhibitors, according to the largest study so far conducted to study the possible link. The findings were reported at the 2016 ACR/ARHP Annual Meeting in an abstract session that also included…